Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OhMD is a private digital health company that provides HIPAA-compliant patient communication software for physician practices, hospitals, and other healthcare organizations. Its platform focuses on reducing inbound call burden and improving patient access through two-way texting, secure messaging, digital forms, web chat, telehealth-related communication, and EHR/PM integrations. In 2025, the company launched Nia, a human-in-the-loop AI voice assistant designed to automate routine patient calls such as scheduling, refills, and basic questions while escalating complex conversations to staff. OhMD is used commercially by medical practices across the United States and positions itself as an operational efficiency and patient engagement platform rather than a therapeutics developer. The company is based in Vermont and remains privately held and venture-backed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OhMD.